(Q43004225)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

12 November 2017

0 references

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma (English)

1 reference

12 November 2017

Y S Guan

1

1 reference

12 November 2017

Y Liu

2

1 reference

12 November 2017

X P Zhou

3

1 reference

12 November 2017

X Li

4

1 reference

12 November 2017

Q He

5

1 reference

12 November 2017

L Sun

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

5 May 2005

1 reference

12 November 2017

1 reference

12 November 2017

54

1 reference

12 November 2017

9

1 reference

12 November 2017

1318-1319

1 reference

Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Segmental transcatheter arterial embolization for primary hepatocellular carcinoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Arterial chemoembolization for hepatocellular carcinoma.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Progress in cancer gene therapy

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Gene therapy of cancer through restoration of tumor-suppressor functions?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774668

p53 status and the efficacy of cancer therapy in vivo

16 August 2018

1 reference

12 December 2020

Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma

1 reference

12 December 2020

Transcatheter arterial embolization for advanced hepatocellular carcinoma resulting in a curative resection: report of two cases

1 reference

12 December 2020

Non-surgical treatment of hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2005.069237

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

15879012

1 reference